The Food and Drug Administration on Tuesday announced it approved Ingrezza (valbenazine) capsules to...

Once-daily treatment with valbenazine (NBI-98854), a highly selective vesicular monoamine transport ...

The Food and Drug Administration (FDA) announced Friday that it will remove the boxed warning relate...

The Food and Drug Administration on Tuesday announced that a new warning of the serious adverse outc...

Modern hypnotic medications are associated with suicidality, but the association may often be confou...

The Food and Drug Administration today announced that it will require class-wide changes to the labe...

Two devices for assessing cognitive function immediately following a suspected brain injury or concu...

As the number of hospitalizations for opioid misuse continues to grow, so too have questions of whet...

All-cause hospitalizations and deaths among veterans significantly increased following reductions in...